Common therapeutic strategies for prion and Alzheimer's diseases.
A number of unexpected pathophysiological connections linking different neurodegenerative diseases have emerged over the past decade. An example is provided by prion and Alzheimer's diseases. Despite being distinct pathologies, these disorders share several neurotoxic mechanisms, including accumulation of misfolded protein isoforms, stress of the protein synthesis machinery, and activation of a neurotoxic signaling mediated by the cellular prion protein. Here, in addition to reviewing these mechanisms, we will discuss the potential therapeutic interventions for prion and Alzheimer's diseases that are arising from the comprehension of their common neurodegenerative pathways.
Saioa R
SR
Elezgarai
Emiliano
E
Biasini
D000544:Alzheimer Disease / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism / Q000628:therapy*; D000818:Animals; D020868:Gene Silencing; D006801:Humans; D018621:PrPC Proteins / Q000172:deficiency / Q000235:genetics / Q000378:metabolism; D017096:Prion Diseases / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism / Q000628:therapy*; D015398:Signal Transduction / Q000187:drug effects
D018621:PrPC Proteins